SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is surging as investors speculate on a potential short squeeze, fueled by high short interest and anticipation surrounding upcoming clinical trial results for its AML therapy. The community is actively debating the stock's future, with many retail investors holding firm for a potential buyout or major institutional catalyst while others remain skeptical about the firm's fundamentals.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple is facing significant market volatility as it implements global price hikes for its Mac and iPad lines, a move attributed to unsustainable memory chip costs driven by the AI infrastructure boom. Community sentiment is deeply divided, with some investors viewing the stock as a discounted long-term compounding opportunity, while others express concerns over demand elasticity and potential political fallout from the company's efforts to source components from blacklisted Chinese suppliers.

RaveDAO is a global community uniting music, technology, and purpose. Since their first sold-out event at Dubai 2024, they have expanded across Europe, the Middle East, North America, and Asia, hosting world-class experiences with over 100,000 total attendees and 3,000+ attendees for each event.  RaveDAO has worked with top-tier artists like Vintage Culture, Don Diablo, Chris Avantgarde, Lilly Palmer, MORTEN, Bassjackers, and GENESI and has support from Binance, OKX, Bitget, and Polygon. RaveDAO is redefining live entertainment in Web3 and has active partnerships with 1001Tracklists, AMF, and Warner Music.  Beyond the dance floor, RaveDAO channels energy and attention toward impact. In 2025 alone, proceeds from its events helped restore sight to 400+ cataract patients in Nepal and fund over 150 meditation programs across the U.S.

RaveDAO

RaveDAO is drawing intense community focus as traders speculate on potential short-squeeze dynamics and the possibility of a return to higher price levels. While some participants are actively accumulating in hopes of a rapid rally, others remain cautious, debating whether recent volatility represents a genuine trend reversal or a recurring pump-and-dump cycle.

USA Rare Earth, Inc. is a domestic supplier of rare earth magnets and heavy rare earth elements. It develops a vertically integrated domestic supply chain for rare earth element magnet production, with a facility in Stillwater and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USA Rare Earth is trending as investors react to a series of high-profile government funding developments and site selection news aimed at bolstering domestic supply chain independence. The community is actively debating the company's ability to navigate regulatory hurdles and potential competition, balancing long-term strategic potential against near-term volatility and concerns over share dilution.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is currently facing intense downward pressure as market participants debate whether recent price action reflects a structural bear market or an accumulation opportunity for institutions. The community remains deeply divided, with discussions centered on corporate influence, macroeconomic inflation concerns, and skepticism surrounding large-scale holdings.

Grayscale Bitcoin Mini Trust ETF - Common units of fractional undivided beneficial interest

Grayscale Bitcoin Mini Trust ETF

The Grayscale Bitcoin Mini Trust is currently trending as investors debate the impact of broader market volatility and shifting institutional sentiment on Bitcoin's long-term value. Community discourse remains highly polarized, with active discussions focused on the potential for a short-term price squeeze, the significance of Bitcoin's recent testing of support levels, and varying outlooks on the role of Bitcoin ETFs in shaping the asset's future trajectory.

Vanguard Index Funds - Vanguard S&P 500 ETF

Vanguard S&P 500 ETF

The VOO ETF is trending as investors aggressively rotate capital from broad indices into targeted semiconductor and AI memory plays amid fluctuating geopolitical tensions. The market is currently focused on navigating S&P 500 index rebalancing and high-conviction institutional rotation as traders weigh compounding long-term growth against short-term macroeconomic uncertainty.

Viridian Therapeutics, Inc. is a biopharmaceutical company that develops medicines for autoimmune and rare diseases. It uses antibody discovery and protein engineering to create new therapies. The company is advancing late-stage IGF-1R therapies for thyroid eye disease (TED) and developing a potential TSHR-targeted treatment for TED and Graves’ disease. In addition, it is developing FcRn inhibitors, including VRDN-006 and VRDN-008, for multiple autoimmune diseases. The company was founded by William S. Marshall and Bruce L. Booth in February 2006 and is headquartered in Waltham, MA.

Viridian Therapeutics Inc

Viridian Therapeutics is capturing market attention following FDA approval of Lumvoa for the treatment of thyroid eye disease, with the community closely tracking the company's immediate commercial launch plans and potential for market share capture. Investors are actively debating the stock's valuation, the competitive landscape against existing treatments, and the prospects for long-term growth as the firm transitions into a commercial-stage entity.

Aurora Innovation, Inc. engages in the design and development of automobile hardware, software, and provision of data services. It offers the Aurora Driver which allows a vehicle to drive itself. The company was founded by Christopher Urmson, Sterling Anderson and James Andrew Bagnell in 2017 and is headquartered in Pittsburgh, PA.

Aurora Innovation Inc - Ordinary Shares - Class A

Aurora Innovation is trending as investors react to positive sentiment surrounding autonomous trucking commercialization, fueled by upcoming product launches and strong community interest in its perception and robotics technology. The stock is seeing heightened engagement from traders who are actively discussing its potential for long-term growth and monitoring technical setups, while weighing the impact of institutional positioning.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood shares are facing downward pressure as investors digest a substantial convertible note offering, while the community remains sharply divided between those viewing the pullback as a strategic buying opportunity and others criticizing the dilution risk. Despite the volatility, sentiment stays focused on the company's aggressive expansion into prediction markets, banking, and international growth as key long-term catalysts.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$IBTA  Ibotta Announces a $100 Million Increase to Its Share Repurchase Program 
 
&quot;Board of Directors authorized the purchase of up to an additional $100 million of the Company&#39;s Class A common stock, effective immediately. This new authorization follows prior Board approval for $300 million repurchase of the Company&#39;s Class A common stock.&quot;

StockTwits Web

Ibotta Inc

  Ibotta Announces a $100 Million Increase to Its Share Repurchase Program 
 
"Board of Directors authorized the purchase of up to an additional $100 million of the Company's Class A common stock, effective immediately. This new authorization follows prior Board approval for $300 million repurchase of the Company's Class A common stock."